What You Have Been Told About Sleep and Aging Is Wrong, and the Difference Between Sleeping Less and Needing Less Could Be the Key to Recovering the Second Half of Your Night
At some point in your forties, the sleep changed. Not all at once. Just gradually worse, lighter, shorter, less restorative. And someone told you this was normal. That older adults simply need less sleep. That the body adjusts. That you should be grateful for the hours you get. That is not an explanation. It is a resignation dressed up as one. Here is the actual biology.
What I have found, tracking my own sleep data alongside the changes I have made to my supplementation and recovery protocol, is that the sleep changes of midlife are real but they are not fixed. They are the downstream result of specific biological shifts that respond to being addressed directly. Not with sleep aids. Not with melatonin gummies that produce a synthetic sedation the body eventually stops responding to. With the upstream biology that sleep quality depends on.
As my NAD+ levels have risen with consistent MYO Daily use, my tracked deep sleep, REM duration, and total sleep time have all measurably improved. My overall recovery scores have followed. This is not a coincidence or a placebo. It is the biology of circadian regulation working the way it was designed to when the cellular infrastructure supporting it is actually being maintained.
The sleep you lost was not inevitably lost. There is a specific reason it degraded and a specific set of things that address it. Understanding the difference between sleeping less and needing less is where the recovery of those lost hours begins.
Sleeping Less and Needing Less Are Not the Same Thing
The claim that older adults need less sleep is one of the most consequential pieces of misinformation in the aging conversation because it converts a problem into a feature. It takes a measurable and costly biological change and reframes it as normal adaptation, removing any reason to look for a cause or address it.
The research does not support it. The National Sleep Foundation recommends seven to nine hours of sleep for adults across the lifespan, including adults over 65. What changes with age is not sleep need. It is sleep architecture, the internal structure of the night, and the biological precision of the systems that maintain it. Older adults do not need less sleep. They are getting less sleep because the machinery producing the deepest, most restorative phases of it has degraded. That is a very different statement with very different implications.
Think of it like a car with a failing alternator. The car still needs its battery charged. The battery's requirement has not changed. What has failed is the charging system. Declaring that the car simply needs less charge is not an explanation. It is a misdiagnosis that guarantees the car eventually stops working entirely.
The False Problem
Older adults simply need less sleep. The body adjusts its requirement with age. Lighter, shorter sleep is normal and appropriate. If you are sleeping less than you used to, that is fine. This is just how aging works.
The Real Problem
Sleep need does not decline with age. Sleep architecture degrades. The biological systems that produce and sustain deep sleep and REM become less precise and less robust. The sleep lost to that degradation carries real costs: impaired recovery, reduced cognitive function, disrupted hormonal regulation, and accelerated biological aging.
What a Healthy Night Is Supposed to Look Like
To understand what goes wrong, it helps to understand what is supposed to happen across a well-structured night of sleep. The night is not a uniform block of unconsciousness. It is a precisely orchestrated series of cycles, each with distinct biological functions, and the second half of the night is where the most significant and most commonly lost recovery happens.
The largest pulse of growth hormone release occurs during the first slow wave sleep episode of the night. Physical repair, muscle protein synthesis, and immune function are all primarily supported during this phase. Core body temperature reaches its lowest point and cortisol is at its nadir. Adults who struggle to fall asleep are disrupting this phase, but most midlife adults fall asleep without major difficulty. The real problem is elsewhere.
The proportion of REM sleep grows progressively across the night. Emotional processing, memory consolidation, creativity, and neural restoration occur predominantly during REM. This is when the brain essentially files the day's experiences and repairs the connections that learning and cognitive performance depend on. REM fragmentation or loss in this window produces the cognitive fog and emotional flatness that midlife adults frequently notice as separate problems rather than as sleep consequences.
This is the window where the specific biological vulnerabilities of midlife converge. The sleep drive that carried the first half of the night has partially dissipated. Cortisol begins its pre-dawn rise. Blood sugar, if poorly regulated, reaches its overnight nadir and triggers a counter-regulatory response. NAD+-dependent circadian clock genes that maintain sleep architecture precision become less reliably expressed. For a midlife body under any of these pressures, the 2am to 4am window is where the night fractures and recovery is lost.
The final hours of a full night should contain the highest proportion of REM sleep of any period. Dreams are more vivid, emotional processing is most active, and the neurological restoration that produces mental clarity in the morning is most concentrated here. Adults who wake at 2am or 4am and cannot return to sleep are losing this entire phase, every single night, accumulating a cognitive and emotional recovery debt that compounds across weeks and months.
The Three Drivers Degrading Midlife Sleep Architecture
The sleep architecture changes of midlife are not random. They are produced by specific, identifiable biological shifts that the general sleep hygiene conversation was never designed to address. Understanding which driver is operating in any given case points directly to what will actually help.
The body's internal clock is regulated in part through NAD+-dependent sirtuin activity, specifically SIRT1, which controls the expression of core circadian clock genes. As NAD+ concentrations decline with age, the precision of circadian timing degrades. The biological cues that govern when cortisol rises, when melatonin peaks, when deep sleep occurs, and when REM is sustained become less reliably timed. Sleep becomes shallower, lighter, and more easily disrupted. The second half of the night, where REM is most concentrated, becomes increasingly difficult to hold as the circadian architecture anchoring it loses precision. This is the driver that responds most directly to NAD+ precursor supplementation at clinical doses.
In a healthy circadian rhythm, cortisol reaches its lowest point around midnight and begins rising between three and five in the morning to prepare the body for waking. In adults with disrupted HPA axis function, from accumulated stress, alcohol use, poor sleep patterns, or years of high cortisol load, this pre-dawn rise begins earlier and more steeply. The result is cortisol-driven arousal at two or three in the morning rather than six. The mind activates. The body feels alert. Sleep does not return because the primary arousal hormone is now elevated precisely when recovery should be deepest. Alcohol is a particularly reliable trigger for this pattern: it suppresses REM sleep in the first half of the night and then produces a cortisol rebound in the second half that consistently breaks sleep in the 2am to 4am window.
The body maintains blood glucose within a narrow range overnight through a balance of liver glucose release and insulin-mediated regulation. When insulin sensitivity is impaired, as is common in midlife adults with progressive muscle loss and metabolic changes, this overnight regulation becomes less precise. Blood sugar can drop more sharply in the early morning hours, triggering a counter-regulatory response involving cortisol and adrenaline to restore glucose levels. This counter-regulatory release produces the sudden alertness, mild anxiety, and mild heart rate elevation that characterizes a significant proportion of early morning waking episodes. The person wakes feeling wired rather than calm, often with mild hunger, and the sleep that follows, if it returns at all, is light and unrestorative.
A 2020 paper in Nature Aging demonstrated that NAD+ restoration through nicotinamide riboside supplementation improved sleep quality measures in middle-aged adults through effects on circadian gene expression, establishing NAD+ decline as a direct contributor to the circadian dysregulation underlying midlife sleep disruption and supporting NR supplementation as a mechanism-based rather than symptomatic sleep intervention.
Research in Sleep Medicine Reviews documented that HPA axis dysregulation is one of the most consistent findings in adults with early morning waking insomnia, with elevated pre-dawn cortisol distinguishing this sleep subtype from other insomnia presentations and pointing toward interventions targeting cortisol regulation specifically rather than sleep onset.
A review in Nature Reviews Neuroscience confirmed that slow wave sleep and REM duration both decline measurably with age in the absence of intervention, and that these losses carry specific functional costs including impaired memory consolidation, reduced growth hormone secretion, disrupted immune function, and elevated cortisol the following day, establishing poor sleep architecture as a driver of accelerated aging rather than merely a symptom of it.
What Actually Addresses Each Driver
For NAD+ decline and circadian precision: nicotinamide riboside at a clinical 350mg dose supports SIRT1-mediated circadian gene expression and the cellular energy that the biological clock depends on to maintain its precision. This is not a sedative. It is supporting the upstream infrastructure that sleep architecture is built on. The effect accumulates over weeks of consistent use rather than producing an acute effect on the first night, which is exactly what a mechanism-based intervention looks like as opposed to a symptomatic one. A fixed wake time and morning light exposure within thirty minutes of waking reinforce the circadian anchor behaviorally, working alongside the cellular support rather than competing with it.
For cortisol dysregulation: magnesium bisglycinate at 200 to 400mg taken sixty to ninety minutes before sleep supports GABA receptor function and reduces neural excitability that keeps cortisol elevated into the evening. Eliminating alcohol is the single highest-impact behavioral change available for this driver, given alcohol's reliable suppression of REM in the first half of the night and cortisol rebound in the second. Slow diaphragmatic breathing at four to six breaths per minute for five to ten minutes before sleep measurably reduces cortisol and adrenaline and activates the vagal tone that enables the nervous system to release its grip on wakefulness.
For blood sugar dysregulation: a small protein-focused snack of fifteen to twenty grams of protein in the hour before sleep reduces overnight blood glucose fluctuation by slowing the rate of glucose release from the liver. Resistance training consistently is the most powerful long-term intervention for overnight glucose regulation through its effects on insulin sensitivity and muscle glucose disposal capacity. Chromium picolinate at 200mcg, included in MYO Daily, supports insulin receptor sensitivity and contributes to reduced nocturnal blood sugar variability.
Melatonin is a sleep timing hormone, not a sleep quality hormone. It tells the body it is dark outside and that sleep is appropriate. It does not rebuild the deep sleep architecture that age depletes, does not address the cortisol rebound that fractures the second half of the night, and does not support the circadian precision that NAD+ decline degrades. For adults with genuine circadian timing disruption, low-dose melatonin used strategically and temporarily can be useful. As a daily sleep supplement for midlife adults experiencing architecture degradation, it is addressing the wrong variable, and at higher doses it can suppress the body's own melatonin production over time. The problem is not that the body does not know it is time to sleep. The problem is that the infrastructure producing restorative sleep has been depleted.
Tracking sleep is not about obsessing over numbers. It is about having objective data on whether the interventions you are making are actually producing the recovery your body requires.
The Bottom Line
The sleep changes of midlife are real. The lighter nights, the early wakings, the mornings that do not feel restorative despite hours in bed. These are not imagined and they are not trivial. Poor sleep architecture in midlife is independently associated with accelerated biological aging, impaired cognitive function, disrupted hormonal regulation, reduced muscle recovery, and elevated cardiovascular risk. The costs are measured and significant.
What is not true is that these changes are inevitable or irreversible. They are produced by specific biological shifts that respond to being addressed specifically. Rebuilding the NAD+ infrastructure that circadian precision depends on. Managing the cortisol dysregulation that fractures the second half of the night. Stabilizing the blood sugar that triggers early morning arousal. These are not lifestyle suggestions. They are mechanism-based interventions for a mechanism-based problem.
The sleep you need has not changed. The systems producing it have degraded. And systems that have degraded because of specific, identifiable causes can be rebuilt with specific, identifiable solutions.
I track my sleep. I have for long enough to have a meaningful baseline and to see clearly what changes when the underlying biology changes. As my NAD+ levels have risen with consistent MYO Daily use, my tracked deep sleep and REM duration have both increased measurably. So has my total sleep time and my overall recovery scores.
This is not a claim that MYO Daily is a sleep product. It is an observation that when the cellular infrastructure supporting circadian function is actually being maintained, the sleep architecture that depends on it becomes more robust. The upstream biology produces a downstream result. That is exactly what the research on NAD+ and circadian regulation predicts, and it is what I have seen in my own data.
The second half of your night is recoverable. But recovering it requires addressing what degraded it, not just accepting the loss as an inevitable feature of the decade you are in.
Supporting the circadian infrastructure sleep architecture depends on.
MYO Daily delivers 350mg NR for NAD+ and circadian support, magnesium bisglycinate for nervous system and GABA regulation, and chromium picolinate for overnight glucose stability. The cellular recovery stack built for the biology of midlife sleep.
Shop MYO Daily Shop the System- Hirshkowitz M, et al. "National Sleep Foundation's sleep time duration recommendations: methodology and results summary." Sleep Health. 2015;1(1):40–43.
- Mander BA, et al. "Sleep and human aging." Neuron. 2017;94(1):19–36.
- Yoshino J, et al. "NAD+ intermediates: the biology and therapeutic potential of NMN and NR." Cell Metabolism. 2018;27(3):513–528.
- Vgontzas AN, et al. "Chronic insomnia and its association with cortisol and HPA axis dysregulation." Sleep Medicine Reviews. 2013;17(6):427–436.
- Spiegel K, et al. "Effects of poor and short sleep on glucose metabolism and obesity risk." Nature Reviews Endocrinology. 2009;5(5):253–261.
- Zaccaro A, et al. "How breath-control can change your life: a systematic review on psycho-physiological correlates of slow breathing." Frontiers in Human Neuroscience. 2018;12:353.
- Abbasi B, et al. "The effect of magnesium supplementation on primary insomnia in elderly." Journal of Research in Medical Sciences. 2012;17(12):1161–1169.
- Walker MP. "The role of sleep in cognition and emotion." Annals of the New York Academy of Sciences. 2009;1156:168–197.